The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy (Q46157399)
Jump to navigation
Jump to search
scientific article published on 19 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy |
scientific article published on 19 January 2009 |
Statements
1 reference
The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy (English)
1 reference
A Vazquez-Martin
1 reference
C Oliveras-Ferraros
1 reference
S del Barco
1 reference
B Martin-Castillo
1 reference
J A Menendez
1 reference
19 January 2009
1 reference
1 reference
20
1 reference
3
1 reference
592-595
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference